Kainos Medicine Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Belfast United Kingdom (1986)

Organization Overview

First Clinical Trial
2011
NCT01348516
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Kainos Medicine Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

km-819 (2 trials)

Drugs in Phase 1 Trials (1)

km-023 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 1)

HIV Infections (Phase 1)

Parkinson Disease (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2